Sign in

CIK 0001785279

  • Emerging growth company

Metagenomi Therapeutics, Inc.

Sign in to watch
Ticker
MGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
813909017
Phone
+1 510-871-4880
Business address
5959 HORTON STREET, 7TH FLOOR, EMERYVILLE, CA, 94608
Former names
Metagenomi, Inc., Metagenomi Technologies, LLC
Open-market buys, last 90 days
$23,401
in 1 filing
Open-market sales, last 90 days
$5,107
in 3 filings

Net +$18,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-08 Wein Matthew Sale −358 $1.16 $415 126,133
2026-06-05 Wein Matthew Sale −558 $1.30 $725 126,491
2026-04-01 Wein Matthew Grant or award +11,000 125,549
2026-04-01 Wein Matthew Grant or award · Stock Option (Right to Buy) +68,000 68,000
2026-03-05 Wein Matthew Sale −482 $1.60 $771 114,549
2025-12-05 Wein Matthew Sale −199 $1.77 $353 115,031
2025-12-01 Wein Matthew Grant or award +96,000 $1.60 $154K 115,230
2025-09-05 Wein Matthew Sale −199 $1.81 $360 19,230
2025-06-06 Wein Matthew Sale −199 $1.75 $348 16,693
2025-04-01 Wein Matthew Grant or award +3,650 13,117
2025-04-01 Wein Matthew Grant or award +3,775 16,892
2025-04-01 Wein Matthew Grant or award · Stock Option (Right to Buy) +21,875 21,875
2025-04-01 Wein Matthew Grant or award · Stock Option (Right to Buy) +22,725 22,725
2025-03-05 Wein Matthew Sale −930 $1.87 $2K 9,467
2024-04-01 Wein Matthew Grant or award +10,397 10,397
2024-04-01 Wein Matthew Grant or award · Stock Option (Right to Buy) +43,717 43,717

Page 1 of 1 · 16 trades